Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

Introduction: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). Methods: A...

Full description

Bibliographic Details
Main Authors: Diana Cristina Henao-Carrillo, Oscar M. Muñoz, Ana M. Gómez, Martín Rondón, Christian Colón, L. Chica, Claudia Rubio, Fabián León-Vargas, Maria Alejandra Calvachi, Ana María Perea
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623718300206